The company recently announced positive data from two Phase II clinical studies, in which QVM149 was shown to be superior to the comparators.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.